US FDA expands use of GSK's Blujepa
Digest more
GSK is officially cutting ties with Ideaya Biosciences, handing back two clinical programs as part of the termination of a ...
In an interview with the BBC, Dame Emma Walmsley says she will not "shy away" from GSK's US expansion.
Dec 12 (Reuters) - The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a ...
By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...
We recently published 13 Best ADR Stocks to Invest In. GSK plc (NYSE:GSK) is one of the best ADR stocks. GSK plc (NYSE:GSK) ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...
GSK plc (NYSE:GSK) is one of the best pharma stocks to invest in. J.P. Morgan analyst Richard Vosser maintained a Sell rating ...
GSK (GSK) stock is in focus as an expert panel of the European Medicines Agency ((EMA)) endorses the company's Arexvy RSV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback